Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (875 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Powder.
Where it fits in the MeSH classification
- Broader topics
- Dosage Forms
Research landscape
PubMed indexes 20,091 records tagged with the MeSH heading “Powders” (counts retrieved 2026-10-31). 6,260 of them (31.2%) were published from 2020 onward, and the busiest period so far is 2020 onward with 6,260 records.
Reviews account for 821 records (4.1%) and meta-analyses for 71. Randomized controlled trials number 908 (4.5%) as a share of all records on the topic.
Show the data
| Period | Records |
|---|---|
| through 1999 | 3,884 |
| 2000-2009 | 3,889 |
| 2010-2019 | 6,058 |
| 2020 onward | 6,260 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 821 | 4.1% |
| Meta-analyses | 71 | 0.4% |
| Randomized controlled trials | 908 | 4.5% |
Method: PubMed query "Powders"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.
Reading the evidence in drugs and chemicals
Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies | 2011 | Research article Design not recorded in structured metadata | 61 | cc by PMID 21845086 · DOI · PMC3155359 |
| Nutritional Value and Biological Activity of Gluten-Free Bread Enriched with Cricket Powder | 2021 | Research article Design not recorded in structured metadata | 39 | cc by PMID 33672127 · DOI · PMC7926918 |
| Diffusion and swelling measurements in pharmaceutical powder compacts using terahertz pulsed imaging | 2015 | Research article Design not recorded in structured metadata | 39 | cc by PMID 25645509 · DOI · PMC4415463 |
| Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial | 2024 | Randomized controlled trial Design not recorded in structured metadata | 17 | cc by PMID 39367018 · DOI · PMC11452624 |
Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies [1]
Abstract reading summary — source excerpts
- Opening excerpt
- The aims of this study were to develop proliposome powders containing isoniazid (INH) in a dry powder aerosol form.
- Closing excerpt
- INH-proliposomes are potential candidates for an alternative tuberculosis treatment.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (195 words)
The aims of this study were to develop proliposome powders containing isoniazid (INH) in a dry powder aerosol form. INH-proliposome powders were prepared by a spray drying method. Proliposome physicochemical properties were determined using cascade impactor, X-ray diffraction and differential scanning calorimetry. The toxicity of proliposomes to respiratory-associated cell lines and its potential to provoke immunological responses from alveolar macrophages (AM) were determined. Free INH and INH-proliposome bioactivities were tested in vitro and in AM infected with Mycobacterium bovis (M. bovis). Aerosolization properties of INH-proliposome powders at 60 L/min, the powders showed mass median aerodynamic diameters of 2.99-4.92 μm, with fine particle fractions (aerosolized particles less than 4.4 μm) of 15-35%. Encapsulation of INH was 18-30%. Proliposome formulations containing INH to mannitol ratios of 4:6 and 6:4 exhibited the greatest overlapping peak between the drug and mannitol. INH-proliposomes were evidently nontoxic to respiratory-associated cells, and did not activate AM to produce inflammatory mediators-including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and nitric oxide-at a toxic level. The efficacy of INH-proliposome against AM infected with M. bovis was significantly higher than that of free INH (p < 0.05). INH-proliposomes are potential candidates for an alternative tuberculosis treatment.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 21845086 · DOI · PMC3155359
Nutritional Value and Biological Activity of Gluten-Free Bread Enriched with Cricket Powder [2]
Abstract reading summary — source excerpts
- Opening excerpt
- Cricket powder, described in the literature as a source of nutrients, can be a valuable ingredient to supplement deficiencies in various food products.
- Closing excerpt
- Our results underscore the benefits of using cricket powder to increase the nutritional value and biological activity of gluten-free food products.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (281 words)
Cricket powder, described in the literature as a source of nutrients, can be a valuable ingredient to supplement deficiencies in various food products. Work continues on the implementation of cricket powder in products that are widely consumed. The aim of this study was to obtain gluten-free bread with a superior nutritional profile by means of insect powder addition. Gluten-free breads enriched with 2%, 6%, and 10% of cricket (Acheta domesticus) powder were formulated and extensively characterized. The nutritional value, as well as antioxidant and β-glucuronidase activities, were assessed after simulated in vitro digestion. Addition of cricket powder significantly increased the nutritional value, both in terms of the protein content (exceeding two-, four-, and seven-fold the reference bread (RB), respectively) and above all mineral compounds. The most significant changes were observed for Cu, P, and Zn. A significant increase in the content of polyphenolic compounds and antioxidant activity in the enriched bread was also demonstrated; moreover, both values additionally increased after the digestion process. The total polyphenolic compounds content increased about five-fold from RB to bread with 10% CP (BCP10), and respectively about three-fold after digestion. Similarly, the total antioxidant capacity before digestion increased about four-fold, and after digestion about six-fold. The use of CP also reduced the undesirable activity of β-glucuronidase by 65.9% (RB vs. BCP10) in the small intestine, down to 78.9% in the large intestine. The influence of bread on the intestinal microflora was also evaluated, and no inhibitory effect on the growth of microflora was demonstrated, both beneficial (Bifidobacterium and Lactobacillus) and pathogenic (Enterococcus and Escherichia coli). Our results underscore the benefits of using cricket powder to increase the nutritional value and biological activity of gluten-free food products.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 33672127 · DOI · PMC7926918
Diffusion and swelling measurements in pharmaceutical powder compacts using terahertz pulsed imaging [3]
Abstract reading summary — source excerpts
- Opening excerpt
- Tablet dissolution is strongly affected by swelling and solvent penetration into its matrix.
- Closing excerpt
- Our results highlight a new application area of TPI in the pharmaceutical sciences that could be of interest in the development and quality testing of advanced drug delivery systems as well as immediate release formulations.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (200 words)
Tablet dissolution is strongly affected by swelling and solvent penetration into its matrix. A terahertz-pulsed imaging (TPI) technique, in reflection mode, is introduced as a new tool to measure one-dimensional swelling and solvent ingress in flat-faced pharmaceutical compacts exposed to dissolution medium from one face of the tablet. The technique was demonstrated on three tableting excipients: hydroxypropylmethyl cellulose (HPMC), Eudragit RSPO, and lactose. Upon contact with water, HPMC initially shrinks to up to 13% of its original thickness before undergoing expansion. HPMC and lactose were shown to expand to up to 20% and 47% of their original size in 24 h and 13 min, respectively, whereas Eudragit does not undergo dimensional change. The TPI technique was used to measure the ingress of water into HPMC tablets over a period of 24 h and it was observed that water penetrates into the tablet by anomalous diffusion. X-ray microtomography was used to measure tablet porosity alongside helium pycnometry and was linked to the results obtained by TPI. Our results highlight a new application area of TPI in the pharmaceutical sciences that could be of interest in the development and quality testing of advanced drug delivery systems as well as immediate release formulations.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 25645509 · DOI · PMC4415463
Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial [4]
Abstract reading summary — source excerpts
- Opening excerpt
- Anemia is highly prevalent globally, especially in young children in low-income countries, where it often overlaps with a high burden of diarrheal disease.
- Closing excerpt
- These increases are most evident in children with baseline iron repletion and are further supported by trend-based statistical analyses.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (199 words)
Anemia is highly prevalent globally, especially in young children in low-income countries, where it often overlaps with a high burden of diarrheal disease. Distribution of iron interventions (as supplements or iron-containing multiple micronutrient powders, MNPs) is a key anemia reduction strategy. Small studies in Africa indicate iron may reprofile the gut microbiome towards pathogenic species. We seek to evaluate the safety of iron and MNPs based on their effects on diversity, composition, and function of the gut microbiome in children in rural Bangladesh as part of a large placebo-controlled randomized controlled trial of iron or MNPs given for 3 months (ACTRN12617000660381). In 923 infants, we evaluate the microbiome before, immediately following, and nine months after interventions, using 16S rRNA gene sequencing and shotgun metagenomics in a subset. We identify no increase in diarrhea with either treatment. In our primary analysis, neither iron nor MNPs alter gut microbiome diversity or composition. However, when not adjusting for multiple comparisons, compared to placebo, children receiving iron and MNPs exhibit reductions in commensal species (e.g., Bifidobacterium, Lactobacillus) and increases in potential pathogens, including Clostridium. These increases are most evident in children with baseline iron repletion and are further supported by trend-based statistical analyses.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39367018 · DOI · PMC11452624
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Dry powder inhaler formulation [5]
- Research article Powder method for detecting latent fingerprints: a review [6]
- Research article Dry powders for oral inhalation free of lactose carrier particles [7]
- Research article Dry powder inhalers (DPIs)--a review of device reliability and innovation [8]
- Research article Physical stability of dry powder inhaler formulations [9]
- Research article The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations [10]
References
- Rojanarat W, Changsan N, Tawithong E, Pinsuwan S, Chan HK, Srichana T. Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies. . 2011. PMID 21845086 · DOI · PMC3155359
- Kowalczewski PŁ, Gumienna M, Rybicka I, Górna B, Sarbak P, Dziedzic K, et al.. Nutritional Value and Biological Activity of Gluten-Free Bread Enriched with Cricket Powder. . 2021. PMID 33672127 · DOI · PMC7926918
- Yassin S, Su K, Lin H, Gladden LF, Zeitler JA. Diffusion and swelling measurements in pharmaceutical powder compacts using terahertz pulsed imaging. . 2015. PMID 25645509 · DOI · PMC4415463
- Baldi A, Braat S, Hasan MI, Bennett C, Barrios M, Jones N, et al.. Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial. . 2024. PMID 39367018 · DOI · PMC11452624
- Telko MJ, Hickey AJ. Dry powder inhaler formulation. Respir Care. 2005. PMID 16122404
- Sodhi GS, Kaur J. Powder method for detecting latent fingerprints: a review. Forensic Sci Int. 2001. PMID 11473799 · DOI
- Healy AM, Amaro MI, Paluch KJ, Tajber L. Dry powders for oral inhalation free of lactose carrier particles. Adv Drug Deliv Rev. 2014. PMID 24735676 · DOI
- Islam N, Gladki E. Dry powder inhalers (DPIs)--a review of device reliability and innovation. Int J Pharm. 2008. PMID 18583072 · DOI
- Shetty N, Cipolla D, Park H, Zhou QT. Physical stability of dry powder inhaler formulations. Expert Opin Drug Deliv. 2020. PMID 31815554 · DOI · PMC6981243
- Jones MD, Price R. The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm Res. 2006. PMID 16845584 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-31.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.